Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
amgen
3
×
biotech
clinical trials
eli lilly
fda
indiana blog main
3
×
indiana top stories
life sciences
3
×
national blog main
boston blog main
chronic migraine
indiana
raleigh-durham blog main
raleigh-durham top stories
teva pharmaceutical
adaptive biotechnologies
alector
allergan
alprazolam
apollomics
bernie sanders
beta bionics
bill & melinda gates foundation trust
black diamond therapeutics
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
calcitonin gene-related peptide
cancer
cancer drugs
cgrp inhibitors
civica rx
colucid pharmaceuticals
deals
detroit blog main
detroit top stories
diabets
drug enforcement administration
drug prices
What
eli
3
×
approval
drug
fda
giant
lilly
migraine
new
pharmaceutical
won
acute
addresses
announced
appetite
approved
bio
black
bread
butter
buyout
cancer
cash
causes
class
condition
decades
decision
developed
diabetes
diamond’s
drugs
friday
giving
grabbed
hasn’t
headache
hold
lasmiditan
late
lilly's
Language
unset
Current search:
eli
×
photo
×
" life sciences "
×
amgen
×
" indiana blog main "
×
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines